ContextVision (CONTX) Q2 2024 earnings summary

Executive summary

• Signed new customers in Asia and North America, expanding presence and potential in the veterinary and North American markets.

• Continued strategic investments in Image Quality and Data Quality businesses, with progress in POCUS product development and advanced partnership negotiations.

• Stable cash flow and strong cash position support ongoing investments and expansion.

• Stable first half-year sales, with a focus on growth and partnership agreements in the pipeline.

Financial highlights

• Q2 net sales were SEK 31.7 million, down 6.2% year-over-year, mainly due to currency headwinds and timing of orders.

• Adjusted EBITDA for Q2 was SEK 9 million (28.4% margin); adjusted operating result was SEK 6.7 million (21.1% margin).

• First half-year net sales totaled SEK 66.4 million, matching the same period last year.

• Cash flow from operating activities in Q2 was SEK 11.8 million, increasing cash position to SEK 76.3 million.

• Adjusted earnings per share for Q2 was 0.07 SEK, compared to 0.14 SEK last year.

Outlook and guidance

• Expectation to continue investing around 10% of net sales into POCUS, with ramp-up phase ongoing.

• Anticipate higher cost levels going forward due to expansion and increased product release frequency.

• Confident in capacity to continue investing in image and data quality to drive long-term growth.

• Market remains stable with 3–4% CAGR; positive sales tendencies from new customers, though effects will take time.